Tao Huang

22PUBLICATIONS
50CO-AUTHORS
Gene and molecular therapyPredictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Sep 09, 2026
Neoadjuvant Pertuzumab Biosimilar HLX11 Versus Reference Pertuzumab for Early-stage or Locally Advanced Breast Cancer: A phase 3 Equivalence Trial.

|Jun 19, 2026
Risk stratification for reoperation outcomes in recurrent or persistent papillary thyroid carcinoma: development and validation of a machine learning model.

|Mar 12, 2026
Declined RTN3 stabilizes DHCR7 to induce cholesterol-dependent tumor progression and MEK inhibitors insensitivity in thyroid cancer.

Anwen Ren, Nan Feng, Tinglin Yang

|Feb 13, 2026
Beyond Chemotherapy: Network Meta-Analysis Reveals Optimal Neoadjuvant Strategies for Luminal Breast Cancer.

Xinyu Li, Peijing Du, Tao Huang

|Dec 30, 2025
Dedifferentiation and Redifferentiation of Follicular-Cell-Derived Thyroid Carcinoma: Mechanisms and Therapeutic Implications.

You He, Zimei Tang, Ming Xu

|Sep 22, 2025
Advances in the intrinsic signaling pathway interactions and clinical translation of HR+/HER2+ breast cancer.

Xinyu Li, Tao Huang

Pageof 4

Frequent Collaborators

5 joint publications

Tinglin Yang

2 joint publications

Zhenghao Wu

2 joint publications

Zimei Tang

2 joint publications

Jie Ming